russ2000_2_0664|VRCA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
russ2000_2_0664|VRCA|Long Name|1|1|Verrica Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Verrica Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Verrica Pharmaceuticals Inc Inventories (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Verrica Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Verrica Pharmaceuticals Inc Book Value (Quarterly) (USD)|Verrica Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Verrica Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc EV to Revenues|Verrica Pharmaceuticals Inc EV to Earnings|Verrica Pharmaceuticals Inc EV to Free Cash Flow|Verrica Pharmaceuticals Inc EV to Assets (Quarterly)|Verrica Pharmaceuticals Inc PS Ratio|Verrica Pharmaceuticals Inc PE Ratio|Verrica Pharmaceuticals Inc Price to Book Value|Verrica Pharmaceuticals Inc PEG Ratio|Verrica Pharmaceuticals Inc Debt to Equity Ratio|Verrica Pharmaceuticals Inc Dividend Yield|Verrica Pharmaceuticals Inc Shareholder Yield (TTM)|Verrica Pharmaceuticals Inc Percent of Shares Outstanding Short|Verrica Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Return on Invested Capital|Verrica Pharmaceuticals Inc Quality Ratio Score|Verrica Pharmaceuticals Inc Momentum Score|Verrica Pharmaceuticals Inc Beta (1Y)|Verrica Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Verrica Pharmaceuticals Inc Institutional Investor Ownership Percentage|Verrica Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Verrica Pharmaceuticals Inc Total Employees (Annual)|Verrica Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Verrica Pharmaceuticals Inc Shares Outstanding|Verrica Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Verrica Pharmaceuticals Inc Payout Ratio|Verrica Pharmaceuticals Inc Quick Ratio (Quarterly)|Verrica Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Verrica Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Verrica Pharmaceuticals Inc Effective Tax Rate (TTM)|Verrica Pharmaceuticals Inc Return on Equity|Verrica Pharmaceuticals Inc Net Income (TTM) (USD)|Verrica Pharmaceuticals Inc Revenue (TTM) (USD)|Verrica Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Verrica Pharmaceuticals Inc Revenue (Quarterly) (USD)|Verrica Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Verrica Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Verrica Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Price (USD)|Verrica Pharmaceuticals Inc Total Return Price (USD)|Verrica Pharmaceuticals Inc Enterprise Value (USD)|Verrica Pharmaceuticals Inc 30-Day Average Daily Volume|Verrica Pharmaceuticals Inc 1 Year Price Returns (Daily)
russ2000_2_0664|VRCA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
russ2000_2_0664|VRCA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
russ2000_2_0664|VRCA||5|5|91.2|91.2|0|91.2|0|91.2|91.2|91.2|0|91.2|91.2|91.2|0|0|1.44949494949|0|0|0|1.44949494949|0|0|1.44949494949|0|15.2363636364|0|91.2|91.2|0|0|30.5|30.5333333333|0|30.5|91.3076923077|182.5|91.3076923077|38.0952380952|0|91.2|0|0|91.3076923077|91.4|0|0|91.2|0|0|0|0|91.3076923077|91.3076923077|91.3076923077|91.3076923077|1.44949494949|1.44949494949|1.44949494949|1.44955752212|1.44023323615
russ2000_2_0664|VRCA||6|6|10|10|0|10|0|10|10|10|0|10|10|10|0|0|594|0|0|0|594|0|0|594|0|55|0|10|10|0|0|14|15|0|14|13|4|13|21|0|10|0|0|13|10|0|0|10|0|0|0|0|13|13|13|13|594|594|594|565|343
russ2000_2_0664|VRCA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
russ2000_2_0664|VRCA|201703|201703|201703||||||||||||||||||||||||||||||||||19.9464||-0.0286||||||-0.0286|||||||||0.055|-0.57|-0.57|0|||||
russ2000_2_0664|VRCA|201706|201706|201706||||||||||||||||||||||||||||||||||19.9464||-0.0549||||||-0.0549|0||||||||0.118|-1.095|-1.095|0|||||
russ2000_2_0664|VRCA|201709|201709|201709||||||||||||||||||||||||||||||||||19.9464||-0.0681||||||-0.0681|0||||||||0.238|-1.359|-1.359|-0.001|||||
russ2000_2_0664|VRCA|201712|201712|201712|9.083|8.663||0||16.124|0.616|15.508||-7.041|-12.435|0||||||||||||||0.167|0|||||||19.9464|11|-0.3377|||24.9464|||-0.0719|0|||-4.459|||||0.316|-1.435|-1.435|-0.001|||||
russ2000_2_0664|VRCA|201803|201803|201803|28.905|27.485||0.019||1.648|1.648|0||27.748|-14.309|0||||||||||||||0.618|0.002|||||||24.9464||-0.074|||24.9464|||-0.074||||-5.736|||||0.961|-1.847|-1.847|0.041|||||
russ2000_2_0664|VRCA|201805|201803|201803|||||||||||||||||||||||||||||||||||||24.9464||||||||||||||||||||||
russ2000_2_0664|VRCA|201806|201806|201806|104.59|103.149||0.112||3.125|3.125|0||101.591|-20.268|0|||-74.6158||||17.7379|||0||0.1227||1.117|0.003|||||||5.7513|11|-0.92|25.6964||25.6964|||-0.92|-86.25|||-9.958|||||1.955|-5.317|-5.317|0.153|19.73|19.73|464.7075||
russ2000_2_0664|VRCA|201807|201806|201806|||||||||||||||-39.2837||||4.4012|||0||0.1284|||||||||||||||||||||||||||||||17.4|17.4|343.9684|30375.0333|
russ2000_2_0664|VRCA|201808|201806|201806|||||||||||||||-39.8707||||4.4517|||0||0.1283|||||||||||||25.6964||||||||||||||||||17.6|17.6|349.1076|50869.6667|
russ2000_2_0664|VRCA|201809|201809|201809|98.677|96.975||0.114||2.451|2.451|0||96.354|-27.007|0|||-35.9088||||4.1103|||0||0.6617||1.105|0.003|||||||24.8475|15|-0.24|25.6964||25.6964|||-0.24|7.876|||-14.505|||||2.865|-5.906|-5.906|0.427|16.25|16.25|314.4175|100175.4667|
russ2000_2_0664|VRCA|201810|201809|201809|||||||||||||||-18.8967||||3.5203|||0||0.4527|||||||||||||||||||||||||||||||13.2|13.2|242.2175|77081.3333|
russ2000_2_0664|VRCA|201811|201809|201809|||||||||||||||-16.491||||3.2002|||0||0.5986|||||||||||||25.6964||||||||||||||||||12|12|211.3818|40105.0333|
russ2000_2_0664|VRCA|201812|201812|201812|91.152|89.809||0.255||2.477|2.477|0||89.429|-33.083||||-6.4181||||2.3426|||0||0.5482||0.96|0.003|||||||25.7048|16|-0.3|25.7048||25.7048|||-0.3|-7.876|||-20.648|||||3.271|-7.578|-7.578|0.61|8.15|8.15|119.6851|42005.3|
russ2000_2_0664|VRCA|201901|201812|201812|||||||||||||||-11.6837||||3.4406|||0||0.6216|||||||||||||||||||||||||||||||11.97|11.97|217.8775|57787.6333|
russ2000_2_0664|VRCA|201902|201812|201812|||||||||||||||-10.7877||||3.2537|||0||1.333|||||||||||||||||||||||||||||||11.32|11.32|201.1693|43699.9667|
russ2000_2_0664|VRCA|201903|201903|201903|84.677|83.282||1.288||3.218|3.062|0.156||82.761|-40.464|0|||-10.0862||||3.1074|||0||2.389|0.006|1.136|0.003|||||||24.8578||-0.3|25.7085||25.7085|||-0.3||||-26.28|||||3.539|-7.479|-7.479|0.547|10.81|10.81|188.0869|75228.5|
russ2000_2_0664|VRCA|201904|201903|201903|||||||||||||||-7.4294||||3.1064|||0||2.3827|||||||||||||25.7085||||||||||||||||||10|10|173.803|39484.8333|
russ2000_2_0664|VRCA|201905|201903|201903|||||||||||||||-4.2754||||2.2148|||0||2.6878|||||||||||||25.7085||||||||||||||||||7.13|7.13|100.0196|33180.2333|
russ2000_2_0664|VRCA|201906|201906|201906|79.739|78.754||1.497||4.405|4.281|0.124||76.845|-47.465|0|||-9.2097||||3.6096|||0||2.8177||1.473|0.003||||3.9747|||24.8756||-0.28|25.7403||25.7403|||-0.28||||-27.964|||||3.593|-7.001|-7.001|0.523|11.62|11.62|215.4508|57742.5333|-40.7143
russ2000_2_0664|VRCA|201907|201906|201906|||||||||||||||-9.5787||||4.1|||0||2.4306||||||3|4.1805||56.9744||||||||||||||||||||||12.24|12.24|236.3073|65088.3|-29.6552
russ2000_2_0664|VRCA|201908|201906|201906|||||||||||||||-7.148||||3.3196|||0||2.3061||||||3|4.3227||56.9655||||25.7413||||||||||||||||||9.91|9.91|176.3423|25903.0667|-43.046
russ2000_2_0664|VRCA|201909|201909|201909|74.04|71.078||2||4.421|4.33|0.091||71.653|-53.555|0|||-11.2632||||5.3032|||0||2.221||1.01|0.003|||3|4.5136||58.6749|24.893||-0.24|25.7448||25.7448|||-0.24|0|||-28.148|||||3.494|-6.09|-6.09|0.453|14.76|14.76|308.9152|62127.7333|-9.1692
russ2000_2_0664|VRCA|201910|201909|201909|||||||||||||||-10.0992||||4.8577|||0||2.6521||||||5|4.7814||58.8117||||||||||||||||||||||13.52|13.52|276.9917|76819.3333|2.4242
russ2000_2_0664|VRCA|201911|201909|201909|||||||||||||||-11.5709||||5.421|||0||1.8805||||||6|4.7894||58.9885||||25.7752||||||||||||||||||15.07|15.07|317.3543|75440.7|29.6902
russ2000_2_0664|VRCA|201912|201912|201912|64.983|62.017||2.201||3.409|3.351|0.058||65.015|-61.192||||-12.379||||6.3023|||0||2.2234||1.185|0.003|||9|5.6428||74.2917|24.9648|17|-0.31|25.7863||25.7863|||-0.31|0|||-28.207|||||4.018|-7.637|-7.637|0.354|15.89|15.89|347.7273|90379.9667|94.9693
russ2000_2_0664|VRCA|202001|201912|201912|||||||||||||||-11.1122||||5.755|||0||2.2639||||||10|5.3838||74.2038||||||||||||||||||||||14.51|14.51|312.1422|74510.3|21.2197
russ2000_2_0664|VRCA|202002|201912|201912|||||||||||||||-8.6887||||4.7079|||0||2.8341||||||8|4.251||74.3075||||||||||||||||||||||11.87|11.87|244.0664|65844.7667|4.8587
russ2000_2_0664|VRCA|202003|202003|202003|90.647|88.382||2.42||37.834|3.302|34.532||56.608|-71.014|0|||-7.6635||||4.9843|||0||3.0879||1.103|0.003|||7|2.8626||71.7619|24.9642||-0.39|25.8145||25.8145|||-0.39||||-30.55|||||4.988|-9.822|-9.822|0.058|10.93|10.93|228.2045|75183.1333|1.1101
russ2000_2_0664|VRCA|202004|202003|202003|||||||||||||||-8.6518||||5.5042|||0||2.9655||||||9|2.2834||58.2015||||25.8145||||||||||||||||||12.07|12.07|257.633|58952.8|20.7
russ2000_2_0664|VRCA|202005|202003|202003|||||||||||||||-8.1403||||5.2351|||0||1.9086||||||9|1.8496||58.1524||||25.8145||||||||||||||||||11.48|11.48|242.4025|51031.8333|42.6087
russ2000_2_0664|VRCA|202006|202006|202006|83.338|79.622||2.517||38.773|38.698|0.075||48.463|-80.423|0|||-7.157||||5.8646|||0||3.2167||1.297|0.003|||9|1.1649||59.9166|24.9656||-0.38|25.8145||25.8145|||-0.38||||-32.958|||||5.11|-9.409|-9.409|-0.778|11.01|11.01|239.3156|74364.5333|-5.2496
russ2000_2_0664|VRCA|202007|202006|202006|||||||||||||||-3.7215||||3.4943|||0||6.2161||||||6|0.7041||59.2057||||25.8145||||||||||||||||||6.56|6.56|124.4411|188022.4|-46.4052
russ2000_2_0664|VRCA|202008|202006|202006|||||||||||||||-5.7519||||4.8952|||0||6.7505||||||2|1.0294||58.6185||||||||||||||||||||||9.19|9.19|192.3333|326652.5667|-7.2654
russ2000_2_0664|VRCA|202009|202009|202009|||||||||||||||-4.6325||||4.1228|||0||9.8796||||||4|1.1071||58.4381||||||||||||||||||||||7.74|7.74|154.9022|236509.4667|-47.561
russ2000_2_0664|VRCA|202010|202009|202009|||||||||||||||-5.1961||||4.5117|||0|||||||||||||||||||||||||||||||||8.47|8.47|173.7468|78610.4667|-40.436